Shares more than doubled in value after Phase 3 results suggested Alumis’ pill may compare favorably with other emerging oral ...
The deal hands Amgen a drug that destroys two proteins known to drive certain types of acute myeloid leukemia, a profile that ...
In a drastic decision made outside of its typical review process, the agency declared it would recommend 11 childhood shots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback